Application of tannic acid in preparation of medicament against respiratory viruses
US12064444B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Sep 10, 2020 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Sep 10, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an application of tannic acid in preparing a medicament against respiratory viruses. The present invention show through live virus experiments that tannic acid has a significant inhibitory effect on respiratory viruses including SARS-CoV-2 coronavirus, Influenza A H1N1 virus, etc., with an exact curative effect, and thus has a broad application prospect in the field of preparation of medicaments against respiratory viruses. In addition, tannic acid exists in a variety of plants, which is a natural active compound existing in nature, and has also been used as a food additive, with a high safety and good foundation for medicament development.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.